Management of Neonatal Isoimmune Disease

Diagnostic Considerations

Obtain cord blood platelet count by clean venipuncture of a cord vessel to assess for concurrent thrombocytopenia, as recommended by the American Society of Hematology 1
Avoid intramuscular injections, including vitamin K, until platelet count is confirmed to be adequate, as suggested by the American Academy of Pediatrics 1
Document any bleeding symptoms, including bruising and petechiae, particularly if thrombocytopenia is present, according to the American College of Obstetricians and Gynecologists 2
Perform complete blood count with peripheral smear to assess degree of hemolysis and exclude other causes, as recommended by the American Society of Hematology 2

Test maternal serum using two different serological methods, including bead-based multiplex assays, MAIPA, or flow-based assays, to ensure concordance, as suggested by the International Society on Thrombosis and Haemostasis 3, 4
Include crossmatch with paternal platelets, if available, to detect alloantibodies to low-frequency antigens, according to the American Association of Blood Banks 3, 5
Obtain serial bilirubin measurements every 4-8 hours in the first 24-48 hours, as bilirubin typically peaks at 24-48 hours after delivery, as recommended by the American Academy of Pediatrics 1

Administer IVIG 1 g/kg for clinical hemorrhage or platelet counts <20,000/μL if thrombocytopenia is present, as suggested by the American Society of Hematology 1

Monitor bilirubin every 4-8 hours as most hemorrhagic and hemolytic events occur 24-48 hours after delivery at the nadir of blood counts, according to the American Academy of Pediatrics 1
Perform transcranial ultrasonography if platelet count <50,000/μL to assess for intracranial hemorrhage, as recommended by the American College of Radiology 1, 2
Continue clinical and hematologic observation through days 2-5 after birth when platelet counts typically reach their nadir, as suggested by the American Society of Hematology 1, 2

Do not rely solely on EDTA plasma samples for antibody detection, as EDTA significantly reduces sensitivity of certain assays, according to the International Society on Thrombosis and Haemostasis 6, 7
Do not assume negative maternal antibody testing excludes isoimmune disease - delayed or low-affinity antibodies may require repeat testing or alternative methods, as suggested by the American College of Obstetricians and Gynecologists 3, 8
Do not use frozen platelets for all antibody testing - certain antigens (cryptic antigens on GPIIbIIIa) are disrupted by freezing and thawing, according to the American Association of Blood Banks 3, 4